NIVESTIM

This brand name is authorized in Australia, Austria, Croatia, Cyprus, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug NIVESTIM contains one active pharmaceutical ingredient (API):

1
UNII PVI5M0M1GW - FILGRASTIM
 

Filgrastim causes marked increases in peripheral blood neutrophil counts within 24 hours, with minor increases in monocytes.

 
Read more about Filgrastim

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
L03AA02 Filgrastim L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AA Colony stimulating factors
Discover more medicines within L03AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 5742F, 5744H, 5829T, 5830W, 6291D, 6292E
DE Bundesinstitut für Arzneimittel und Medizinprodukte 06439441, 06439458, 06439464, 10541843, 10541866, 10713066, 10713072, 10917320, 11004426, 11004432, 11084514, 11084537, 11141459, 11167683, 11314405, 11320966, 11563479, 11646366, 11649235, 12393157, 12393252, 12566959, 12566965, 13568506, 13881812, 13881829, 14307162, 14310017, 14310023, 15433940, 15433957, 16596822, 16678833
EE Ravimiamet 1482083, 1482094, 1482106, 1482117, 1482128, 1482139, 1482140, 1482151, 1482162, 1726545, 1726556, 1726567
ES Centro de información online de medicamentos de la AEMPS 110631001, 110631002, 110631004, 110631005, 110631007, 110631008
FI Lääkealan turvallisuus- ja kehittämiskeskus 100581, 100614, 100648
FR Base de données publique des médicaments 65387858, 69287684, 69908842
GB Medicines & Healthcare Products Regulatory Agency 174427, 174433, 174438
HK Department of Health Drug Office 60949, 60950, 60951
IE Health Products Regulatory Authority 88537, 88538, 88539
IT Agenzia del Farmaco 040158014, 040158026, 040158038, 040158040, 040158053, 040158065, 040158077, 040158089, 040158091, 040158103, 040158115, 040158127
LT Valstybinė vaistų kontrolės tarnyba 1055603, 1055604, 1055605, 1055606, 1055607, 1055608, 1055609, 1055610, 1055611, 1080856, 1080857, 1080858
NL Z-Index G-Standaard, PRK 41831, 41858
NZ Medicines and Medical Devices Safety Authority 14984, 14985, 14986
PL Rejestru Produktów Leczniczych 100254826, 100254832, 100254849
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W64857001, W64857002, W64857003, W64858001, W64858002, W64858003
SG Health Sciences Authority 14195P, 14196P, 14197P
TN Direction de la Pharmacie et du Médicament 13613041H, 13613042H
TR İlaç ve Tıbbi Cihaz Kurumu 8699643950036, 8699643950043, 8699643950050, 8699643950067, 8699643950081, 8699643950098

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.